Tiger Brokers

iX Biopharma issues 32,000 new shares after warrant exercise

SGX Filings
Apr 28

iX Biopharma Ltd. announced that it has allotted and issued 32,000 new ordinary shares on Apr, 28 2026 following the exercise of warrants at 0.06 Singapore dollars per share.

The issuance raises the company’s total share count to 1,050,752,024 from 1,050,720,024.

The new shares rank pari passu with existing shares and are expected to begin trading on the Singapore Exchange on or around Apr, 30 2026.

Following this exercise, 19,992,579 warrants—34.76% of the total originally issued—have been exercised, leaving 37,516,900 warrants outstanding. The remaining warrants carry an exercise price of 0.06 Singapore dollars and will expire on Jul, 18 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10